 SAN DIEGO, Jan. 07, 2021 GLOBE NEWSWIRE -- AnaptysBio, Inc. Nasdaq: ANAB, a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 9:10 a.m. ET. The conference will be conducted virtually, and the audio presentation will be available via 